RSCM
SLDB icon

Rock Springs Capital Management’s Solid Biosciences SLDB Stock Holding History

Rock Springs Capital Management’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-4,000
Closed -$552K – 138
2019
Q1 		$552K Buy
4,000
+67
+2% +$16.8K 0.02% 130
2018
Q4 		$1.58M Sell
3,933
-2,400
-38% -$1.13M 0.07% 125
2018
Q3 		$4.48M Hold
6,333
– – 0.16% 122
2018
Q2 		$3.38M Sell
6,333
-2,000
-24% -$615K 0.13% 127
2018
Q1 		$938K Buy
+8,333
New +$2.81M 0.04% 145

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Rock Springs Capital Management's SLDB Position: Q2 2019 in Review

Rock Springs Capital Management sold out of Solid Biosciences (SLDB) in Q2 2019, closing a stake of 4,000 shares — an estimated $552K sold.

Rock Springs Capital Management first reported a position in SLDB in Q1 2018 and held it in 5 quarters. The position peaked at $4.48M in Q3 2018. 74 funds tracked by Wall St. Rank hold SLDB as of Q2 2019.

  • Rock Springs Capital Management reported no remaining Solid Biosciences position as of Q2 2019 after selling out during the quarter.
  • Rock Springs Capital Management sold 4,000 Solid Biosciences shares in Q2 2019, an estimated $552K.
  • Rock Springs Capital Management first reported a position in Solid Biosciences in Q1 2018 and held it in 5 quarters.
  • Rock Springs Capital Management's Solid Biosciences position peaked at $4.48M in Q3 2018.
  • 74 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2019.

Based on Rock Springs Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.